{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:02:21Z","timestamp":1793397741574,"version":"4.5.0"},"reference-count":515,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.survophthal.2005.04.009","type":"journal-article","created":{"date-parts":[[2005,6,19]],"date-time":"2005-06-19T07:07:29Z","timestamp":1119164849000},"page":"297-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":333,"title":["Current Concepts in the Etiology and Treatment of Beh\u00e7et Disease"],"prefix":"10.1016","volume":"50","author":[{"given":"Cem","family":"Evereklioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2005.04.009_bib1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0954-6111(96)90118-3","article-title":"Beh\u00e7et's disease with pulmonary involvement, superior vena cava syndrome, chyloptysis and chylous ascites","volume":"90","author":"Abadog\u02d8lu","year":"1996","journal-title":"Respir Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib2","first-page":"495","article-title":"Polymorphonuclear leukocyte myeloperoxidase levels in patients with Beh\u00e7et's disease","volume":"18","author":"Accardo-Palumbo","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s002960100102","article-title":"Azathiopine-steroid combination therapy for pulmonary arterial aneurysms in Beh\u00e7et's disease","volume":"20","author":"Acican","year":"2001","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.survophthal.2005.04.009_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1468-3083.2004.00907.x","article-title":"Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Beh\u00e7et's disease","volume":"18","author":"Adam","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/hmg\/ddg066","article-title":"Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC","volume":"12","author":"Ahmad","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.survophthal.2005.04.009_bib6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/art.10815","article-title":"Mapping the HLA association in Beh\u00e7et's disease: a role for tumor necrosis factor polymorphisms?","volume":"48","author":"Ahmad","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.anl.2003.07.006","article-title":"Beh\u00e7et's disease and hearing loss","volume":"31","author":"Ak","year":"2004","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.survophthal.2005.04.009_bib8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.47102\/annals-acadmedsg.V33N5p596","article-title":"Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Beh\u00e7et's disease","volume":"33","author":"Akdeniz","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.survophthal.2005.04.009_bib9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00234-003-1102-1","article-title":"Cranial MRI in Beh\u00e7et's disease: 134 examinations of 98 patients","volume":"45","author":"Akman-Demir","year":"2003","journal-title":"Neuroradiology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib10","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurological involvement in Beh\u00e7et's disease: evaluation of 200 patients. The Neuro-Beh\u00e7et Study Group","volume":"122","author":"Akman-Demir","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2005.04.009_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1053\/sarh.2002.31721","article-title":"Renal Beh\u00e7et's disease: a cumulative analysis","volume":"31","author":"Akpolat","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib12","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/ndt\/gfg084","article-title":"Beh\u00e7et's disease and renal failure","volume":"18","author":"Akpolat","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.survophthal.2005.04.009_bib13","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/rheumatology\/38.12.1279","article-title":"Prevalences of hepatitis A, B, C and E viruses in Beh\u00e7et's disease","volume":"38","author":"Aksu","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.survophthal.2005.04.009_bib14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/rheumatology\/40.6.687","article-title":"Hyperhomocysteinaemia in Beh\u00e7et's disease","volume":"40","author":"Aksu","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.survophthal.2005.04.009_bib15","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jnnp.74.5.608","article-title":"Prevalence and patterns of neurological involvement in Beh\u00e7et's disease: a prospective study from Iraq","volume":"74","author":"Al-Araji","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.survophthal.2005.04.009_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-510X(99)00165-3","article-title":"Neuro-Beh\u00e7et's disease in Iraq: a study of 40 patients","volume":"170","author":"Al-Fahad","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.survophthal.2005.04.009_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1399-5618.2004.00114.x","article-title":"Resistant bipolar disorder precipitated by Beh\u00e7et's syndrome","volume":"6","author":"Alevizos","year":"2004","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.survophthal.2005.04.009_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0887-8994(01)00314-9","article-title":"Cerebral vein thrombosis in Beh\u00e7et's disease","volume":"25","author":"Alper","year":"2001","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000074113","article-title":"Review of the chronology of clinical manifestations in 60 patients with Beh\u00e7et's disease","volume":"207","author":"Alpsoy","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.138.4.467","article-title":"Interferon alfa-2a in the treatment of Beh\u00e7et disease: a randomized placebo-controlled and double-blind study","volume":"138","author":"Alpsoy","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000081480","article-title":"Androgen receptor levels of oral and genital ulcers and skin pathergy test in patients with Beh\u00e7et's disease","volume":"210","author":"Alpsoy","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archderm.135.5.529","article-title":"The use of sucralfate suspension in the treatment of oral and genital ulceration of Beh\u00e7et disease: a randomized, placebo-controlled, double-blind study","volume":"135","author":"Alpsoy","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1468-3083.2003.00625.x","article-title":"Histological and immunofluorescence findings of non-follicular papulopustular lesions in patients with Beh\u00e7et's disease","volume":"17","author":"Alpsoy","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s100670200004","article-title":"Glomerulonephritis in Beh\u00e7et's disease: report of seven cases and review of the literature","volume":"21","author":"Altiparmak","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib25","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/art.20873","article-title":"Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Beh\u00e7et's disease","volume":"52","author":"Amoura","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0021-5155(99)00029-5","article-title":"Epidemiological features and visual prognosis of Beh\u00e7et's disease","volume":"43","author":"Ando","year":"1999","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib27","first-page":"414","article-title":"[Treatment of severe Beh\u00e7et's disease with anti-TNF-\u03b1: infliximab. A case report]","volume":"153","author":"Andreu","year":"2002","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.survophthal.2005.04.009_bib28","first-page":"181","article-title":"Treatment of refractory vitritis in Beh\u00e7et disease with infliximab","volume":"46","author":"Arayssi","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib29","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1346-8138.2003.tb00442.x","article-title":"Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Beh\u00e7et's disease","volume":"30","author":"Aridogan","year":"2003","journal-title":"J Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.thromres.2004.08.010","article-title":"Elevated FVIII and FIX level in a Beh\u00e7et's disease patient with intracardiac thrombosis and pulmonary arterial aneurysms","volume":"115","author":"Atalay","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.survophthal.2005.04.009_bib31","first-page":"S17","article-title":"The effects of nitric oxide donors and inhibitors on neutrophil functions in Beh\u00e7et's disease","volume":"20","author":"Atalay","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00296-003-0398-9","article-title":"Serum homocysteine level is higher in Behcet's disease with vascular involvement","volume":"25","author":"Ate\u015f","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.survophthal.2005.04.009_bib33","first-page":"321","article-title":"The efficacy of cyclosporin A in the treatment of Beh\u00e7et's disease","volume":"25","author":"Atmaca","year":"1994","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.survophthal.2005.04.009_bib34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF00695247","article-title":"Retinal and disc neovascularization in Beh\u00e7et's disease and efficacy of laser photocoagulation","volume":"234","author":"Atmaca","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib35","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1136\/bjo.87.12.1466","article-title":"Fluorescein and indocyanine green angiography findings in Beh\u00e7et's disease","volume":"87","author":"Atmaca","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib36","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000018221","article-title":"Helicobacter pylori and Beh\u00e7et's disease","volume":"199","author":"Avci","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.exer.2004.06.001","article-title":"Etanercept treatment in the endotoxin-induced uveitis of rats","volume":"79","author":"Avunduk","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2005.04.009_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00296-002-0180-4","article-title":"Serum beta 2-microglobulin reflects disease activity in Beh\u00e7et's disease","volume":"22","author":"Ayg\u00fcnd\u00fcz","year":"2002","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.survophthal.2005.04.009_bib39","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1528-1157.2002.01102.x","article-title":"Epileptic seizures in Beh\u00e7et disease","volume":"43","author":"Aykutlu","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.survophthal.2005.04.009_bib40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1365-4362.2003.01893.x","article-title":"Prevalence of Beh\u00e7et's disease in Istanbul, Turkey","volume":"42","author":"Azizlerli","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000246374","article-title":"Interferon alfa-2a in the treatment of Beh\u00e7et's disease","volume":"192","author":"Azizlerli","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3349\/ymj.1997.38.6.437","article-title":"The influence of pregnancy on Beh\u00e7et's disease","volume":"38","author":"Bang","year":"1997","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.survophthal.2005.04.009_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1076\/ocii.12.1.53.28062","article-title":"The demonstration of serum interleukin 6-8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Beh\u00e7et's disease with ocular involvement","volume":"12","author":"Bardak","year":"2004","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2005.04.009_bib44","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/rheumatology\/38.12.1171","article-title":"Beh\u00e7et's syndrome","volume":"38","author":"Barnes","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.survophthal.2005.04.009_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1600-0420.2003.00068.x","article-title":"Factor V Leiden and prothrombin gene G20210A mutations in ocular Beh\u00e7et disease","volume":"81","author":"Batio\u011flu","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.survophthal.2005.04.009_bib46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1583\/03-1037.1","article-title":"Endovascular repair of concomitant celiac trunk and abdominal aortic aneurysms in a patient with Beh\u00e7et's disease","volume":"11","author":"Bautista-Hernandez","year":"2004","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.survophthal.2005.04.009_bib47","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/pgmj.2003.017756","article-title":"Neurotological status in Beh\u00e7et's disease and its ophthalmological correlates","volume":"80","author":"Bayazit","year":"2004","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.survophthal.2005.04.009_bib48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00004836-200003000-00006","article-title":"Gastrointestinal manifestations of Beh\u00e7et's disease","volume":"30","author":"Bayraktar","year":"2000","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib49","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s00234-003-1052-7","article-title":"Proton MRS in Beh\u00e7et's disease with and without neurological findings","volume":"45","author":"Baysal","year":"2003","journal-title":"Neuroradiology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib50","first-page":"1152","article-title":"Uber rezidivierende Aphthose, durch ein Virus verursachte Geschwure am Mund, am Auge und an den Genitalien","volume":"105","author":"Beh\u00e7et","year":"1937","journal-title":"Dermatol Wochenschr"},{"key":"10.1016\/j.survophthal.2005.04.009_bib51","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/art.20334","article-title":"Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Beh\u00e7et's disease","volume":"50","author":"Ben Ahmed","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib52","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bjo.70.8.589","article-title":"Treatment and visual prognosis in Beh\u00e7et's disease","volume":"70","author":"BenEzra","year":"1986","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib53","first-page":"136","article-title":"Evaluation of conventional therapy versus cyclosporine A in Beh\u00e7et's syndrome","volume":"20","author":"BenEzra","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/j.survophthal.2005.04.009_bib54","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0002-9394(14)71071-2","article-title":"Blood serum interleukin-1 receptor antagonist in pars planitis and ocular Beh\u00e7et disease","volume":"123","author":"BenEzra","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib55","article-title":"Long-term treatment of refractory posterior uveitis with anti-TNF\u03b1 (infliximab)","author":"Benitez-De-Castillo","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2005.04.009_bib56","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1346-8138.2004.tb00531.x","article-title":"Peripheral neuropathy in Beh\u00e7et's disease","volume":"31","author":"Birol","year":"2004","journal-title":"J Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib57","first-page":"1283","article-title":"Intercellular adhesion molecule-1 gene polymorphisms in Beh\u00e7et's disease","volume":"28","author":"Boiardi","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib58","unstructured":"Borlu M, Uk\u015fal \u00dc, Ferahba\u015f A, Evereklioglu C: Clinical features of Beh\u00e7et's disease in children. Int J Dermatol (in press)"},{"key":"10.1016\/j.survophthal.2005.04.009_bib59","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0008-6363(98)00228-4","article-title":"Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells","volume":"41","author":"Bouloumi\u00e9","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.survophthal.2005.04.009_bib60","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000083832","article-title":"Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis","volume":"33","author":"Bouma","year":"2004","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.survophthal.2005.04.009_bib61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0039-6257(01)00275-2","article-title":"Immunopathology of the noninfectious posterior and intermediate uveitides","volume":"46","author":"Boyd","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib62","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1525-1470.2001.018002143.x","article-title":"Successful thalidomide treatment of severe infantile Beh\u00e7et's disease","volume":"18","author":"Brik","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib63","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/bjo.82.7.826","article-title":"Role of the endothelium in modulating functional responses of isolated bovine anterior ciliary arteries to vasoconstrictor agonists","volume":"82","author":"Buckley","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib64","first-page":"274","article-title":"Serum adenosine deaminase levels in patients with psoriasis: a prospective case-control study","volume":"10","author":"B\u00fck\u00fclmez","year":"2000","journal-title":"EurJ Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib65","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10384-003-0024-0","article-title":"Color doppler imaging of ocular hemodynamic changes in Beh\u00e7et's disease","volume":"48","author":"Caca","year":"2004","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib66","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.84.2.154","article-title":"Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease","volume":"84","author":"Cahill","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib67","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9343(99)00408-8","article-title":"Thalidomide: current and potential clinical applications","volume":"108","author":"Calabrese","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib68","first-page":"100","article-title":"Correlation of clinical, MRI and Tc-99m HMPAO SPECT findings in neuro-Beh\u00e7et's disease","volume":"104","author":"Cengiz","year":"2004","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.survophthal.2005.04.009_bib69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00004397-199503520-00006","article-title":"Beh\u00e7et's disease","volume":"35","author":"Chavis","year":"1995","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.survophthal.2005.04.009_bib70","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.0906-6705.2005.00253.x","article-title":"Specific interleukin-1 gene polymorphisms in Turkish patients with Beh\u00e7et's disease","volume":"14","author":"Co\u015fkun","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib71","first-page":"53","article-title":"Prevalence of Beh\u00e7et's disease in rural western Turkey: a preliminary report","volume":"22","author":"\u00c7akir","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib72","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000246336","article-title":"Effect of prophylactic benzathine penicilline on mucocutaneous symptoms of Beh\u00e7et's disease","volume":"192","author":"\u00c7alg\u00fcneri","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib73","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/art.1780391216","article-title":"The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Beh\u00e7et's disease: a randomized clinical trial","volume":"39","author":"\u00c7alg\u00fcneri","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s10067-004-0944-1","article-title":"Transverse myelitis in a patient with Beh\u00e7et's disease: favorable outcome with a combination of interferon-\u03b1","volume":"24","author":"\u00c7alg\u00fcneri","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib75","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/ard.62.5.492","article-title":"Effects of interferon-\u03b1 treatment on the clinical course of refractory Beh\u00e7et's disease: an open study","volume":"62","author":"\u00c7alg\u00fcneri","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib76","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00296-003-0301-8","article-title":"Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Beh\u00e7et's disease","volume":"23","author":"Canataroglu","year":"2003","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.survophthal.2005.04.009_bib77","first-page":"1332","article-title":"Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Beh\u00e7et's disease","volume":"24","author":"Carletto","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib78","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1046\/j.1365-4362.2003.01688.x","article-title":"Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Beh\u00e7et's syndrome","volume":"42","author":"Cekmen","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib79","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s004150070049","article-title":"Anti-\u03b1\u03b2-crystallin immunoreactivity in inflammatory nervous system diseases","volume":"247","author":"\u00c7elet","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib80","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/euje.3.3.233","article-title":"Beh\u00e7et's disease with a large and free right atrial thrombus","volume":"3","author":"Cemri","year":"2002","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.survophthal.2005.04.009_bib81","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0022-5347(01)62060-3","article-title":"Bladder involvement in Beh\u00e7et's syndrome","volume":"161","author":"\u00c7etinel","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib82","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1024\/0301-1526.32.3.149","article-title":"Surgical treatment of vasculo-Beh\u00e7et's disease. A review of patients with concomitant multiple aneurysms and venous lesions","volume":"32","author":"Ceyran","year":"2003","journal-title":"Vasa"},{"key":"10.1016\/j.survophthal.2005.04.009_bib83","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0735-1097(00)01137-2","article-title":"Vascular endothelial function and oxidative stress mechanisms in patients with Beh\u00e7et's syndrome","volume":"37","author":"Chambers","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib84","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/bjo.76.8.499","article-title":"Beh\u00e7et's disease: activated T lymphocytes in retinal perivasculitis","volume":"76","author":"Charteris","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib85","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1152\/ajpheart.2001.280.5.H2357","article-title":"Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release","volume":"280","author":"Cho","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib86","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/01.ju.0000081957.90395.4c","article-title":"Clinical features of patients with Beh\u00e7et's disease and epididymitis","volume":"170","author":"Cho","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib87","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/BF02235590","article-title":"Long-term clinical course and prognostic factors in intestinal Beh\u00e7et's disease","volume":"43","author":"Choi","year":"2000","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V90.1.1","article-title":"Homocysteine and thrombotic disease","volume":"90","author":"D'Angelo","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.survophthal.2005.04.009_bib89","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/0-306-48382-3_118","article-title":"High dose methotrexate for ocular lesions of Beh\u00e7et's disease. Preliminary short-term results","volume":"528","author":"Davatchi","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib90","first-page":"356","article-title":"Methotrexate for ocular lesions of Beh\u00e7et's disease. Cohort study on 262 patients","volume":"41","author":"Davatchi","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib91","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/rheumatology\/27.4.300","article-title":"Treatment with acyclovir does not affect orogenital ulcers in Beh\u00e7et's syndrome: a randomized double-blind trial","volume":"27","author":"Davies","year":"1988","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib92","first-page":"3233","article-title":"Human S-antigen determinant recognition in uveitis","volume":"42","author":"de Smet","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2005.04.009_bib93","first-page":"3480","article-title":"Prospective determination of T-cell responses to S-antigen in Beh\u00e7et's disease patients and controls","volume":"41","author":"de Smet","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2005.04.009_bib94","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s102270000022","article-title":"Tacrolimus in dermatology","volume":"5","author":"D\u00e9 Tran","year":"2001","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.survophthal.2005.04.009_bib95","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0248-8663(99)80105-2","article-title":"Treatment of recurrent ulceration with low doses of thalidomide: pilot study in 17 patients","volume":"20","author":"de Wazieres","year":"1999","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.survophthal.2005.04.009_bib96","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1046\/j.1523-1747.2003.12565.x","article-title":"Thalidomide inhibits tumor necrosis factor-\u03b1 production and antigen presentation by Langerhans cells","volume":"121","author":"Deng","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib97","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bjo.79.1.81","article-title":"Experimental approaches to specific immunotherapies in autoimmune disease. Future treatment of endogenous posterior uveitis?","volume":"97","author":"Dick","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib98","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/ard.60.11.996","article-title":"Beh\u00e7et's disease: infectious aetiology, new autoantigens, and HLA-B51","volume":"60","author":"Direskeneli","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib99","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2249.1999.00931.x","article-title":"Oligoclonal T cell expansions in patients with Beh\u00e7et's disease","volume":"117","author":"Direskeneli","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib100","first-page":"708","article-title":"T cell responses to 60\/65 kDa heat shock protein derived peptides in Turkish patients with Beh\u00e7et's disease","volume":"27","author":"Direskeneli","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib101","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02208085","article-title":"Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Beh\u00e7et's disease","volume":"14","author":"Direskeneli","year":"1995","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib102","first-page":"44","article-title":"The role of heat shock proteins in Beh\u00e7et's disease","volume":"21","author":"Direskeneli","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib103","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.thromres.2004.09.010","article-title":"Thrombin activatable fibrinolysis inhibitor in Beh\u00e7et's disease","volume":"115","author":"D\u00f6nmez","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.survophthal.2005.04.009_bib104","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0140-6736(05)74255-0","article-title":"Beh\u00e7et's disease and interferon: flaws in research integrity of randomized trial","volume":"356","author":"D\u00fcndar","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2005.04.009_bib105","unstructured":"Duygulu F, Evereklioglu C, \u00c7ali\u015f M, et al: Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Beh\u00e7et's disease; a pilot study. Clin Rheumatol (in press)"},{"key":"10.1016\/j.survophthal.2005.04.009_bib106","first-page":"93","article-title":"Polymorphisms of the IL-8 and CXCR2 genes are not associated with Beh\u00e7et's disease","volume":"32","author":"Duymaz-Tozkir","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib107","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00296-003-0302-7","article-title":"Erosive arthritis in a patient with Beh\u00e7et's disease","volume":"23","author":"D\u00fczg\u00fcn","year":"2003","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.survophthal.2005.04.009_bib108","first-page":"17","article-title":"Serum soluble CD30 levels in Beh\u00e7et's disease","volume":"22","author":"D\u00fczg\u00fcn","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib109","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/sj.bdj.4809326","article-title":"Use of proprietary agents to relieve recurrent aphthous stomatitis","volume":"182","author":"Edres","year":"1997","journal-title":"Br Dent J"},{"key":"10.1016\/j.survophthal.2005.04.009_bib110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/08830189709116846","article-title":"Vasculitis in Beh\u00e7et's disease","volume":"14","author":"Ehrlich","year":"1997","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib111","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s002960050094","article-title":"Increased CD4+CD56+ T cell subsets in Beh\u00e7et's disease","volume":"19","author":"Ek\u015fioglu-Demiralp","year":"1999","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.survophthal.2005.04.009_bib112","first-page":"826","article-title":"Phenotypic characteristics of B cells in Beh\u00e7et's disease: increased activity in B cell subsets","volume":"26","author":"Ek\u015fioglu-Demiralp","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib113","first-page":"2254","article-title":"Renal involvement in Beh\u00e7et's disease: review of 9 cases","volume":"25","author":"El Ramahi","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib114","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00061198-200412000-00002","article-title":"Incidence of secondary glaucoma in Beh\u00e7et disease","volume":"13","author":"Elgin","year":"2004","journal-title":"J Glaucoma"},{"key":"10.1016\/j.survophthal.2005.04.009_bib115","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/000348949110000607","article-title":"Effect of cyclosporine A on the hearing loss in Beh\u00e7et's disease","volume":"100","author":"Elidan","year":"1991","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib116","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/bjo.86.6.653","article-title":"Serum homocysteine level is increased and correlated with endothelin1 and nitric oxide in Beh\u00e7et's disease","volume":"86","author":"Er","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib117","article-title":"Vascular endothelial and basic fibroblast growth factor serum levels in patients with Beh\u00e7et's disease","volume":"15","author":"Erdem","year":"2004","journal-title":"Rheumatol Int, (in press)"},{"key":"10.1016\/j.survophthal.2005.04.009_bib118","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/BTER:95:2:97","article-title":"Serum levels of vitamins A, C, and E, beta-carotene, selenium, and zinc in patients with Beh\u00e7et's disease: a controlled study","volume":"95","author":"Erel","year":"2003","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.survophthal.2005.04.009_bib119","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1067\/mjd.2001.117728","article-title":"HSP 60 expression in mucocutaneous lesions of Beh\u00e7et's disease","volume":"45","author":"Erg\u00fcn","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib120","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1164\/ajrccm\/146.1.232","article-title":"Pulmonary vasculitis in Beh\u00e7et's disease","volume":"146","author":"Erkan","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib121","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/thorax.56.7.572","article-title":"Pulmonary manifestations of Beh\u00e7et's disease","volume":"56","author":"Erkan","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.survophthal.2005.04.009_bib122","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0272-5231(01)00014-4","article-title":"Pulmonary complications of Beh\u00e7et's disease","volume":"23","author":"Erkan","year":"2002","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib123","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/0962935031000097754","article-title":"Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Beh\u00e7et's disease: original contributions\/clinical and laboratory investigations","volume":"12","author":"Erkili\u00e7","year":"2003","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.survophthal.2005.04.009_bib124","first-page":"32","article-title":"Comparative evaluation of the effectiveness of corticosteroids and cytostatics in treating retinal angiitis in Beh\u00e7et's disease","volume":"118","author":"Ermakova","year":"2002","journal-title":"Vestn Oftalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib125","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/ard.60.8.814","article-title":"Parvovirus B19 infection in Beh\u00e7et's disease","volume":"60","author":"Kiraz","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib126","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1046\/j.1365-2249.1997.d01-947.x","article-title":"Peripheral blood T cell expansions in patients with Beh\u00e7et's disease","volume":"107","author":"Esin","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib127","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9343(01)01048-8","article-title":"Vascular involvement in Beh\u00e7et's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin","volume":"112","author":"Espinosa","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib128","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/rheumatology\/41.10.1213-c","article-title":"Beh\u00e7et's syndrome: response to infliximab after failure of etanercept","volume":"41","author":"Estrach","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.survophthal.2005.04.009_bib129","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/515313","article-title":"Tumor necrosis factor-\u03b1, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis","volume":"177","author":"Evans","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1517\/14656566.5.2.317","article-title":"Managing the symptoms of Beh\u00e7et's disease","volume":"5","author":"Evereklioglu","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.survophthal.2005.04.009_bib131","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/09629350310001599710","article-title":"The pathophysiological significance of red blood cell nitric oxide concentrations in inflammatory Beh\u00e7et's disease","volume":"12","author":"Evereklioglu","year":"2003","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.survophthal.2005.04.009_bib132","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1258\/0022215011908946","article-title":"Audio-vestibular evaluation in patients with Beh\u00e7et's syndrome","volume":"115","author":"Evereklioglu","year":"2001","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib133","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/112067210201200105","article-title":"Increased corneal thickness in active Beh\u00e7et's disease","volume":"12","author":"Evereklioglu","year":"2002","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib134","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09629350220131935","article-title":"Serum levels of TNF-a, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Beh\u00e7et's disease","volume":"11","author":"Evereklioglu","year":"2002","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.survophthal.2005.04.009_bib135","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2133.2002.04703.x","article-title":"Serum leptin concentration is increased in patients with Beh\u00e7et's syndrome and is correlated with disease activity","volume":"147","author":"Evereklioglu","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib136","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1440-1797.2003.00180.x","article-title":"Urinary nitric oxide levels are increased and correlated with plasma concentrations in patients with Beh\u00e7et's disease: Is it a new urinary activity marker?","volume":"8","author":"Evereklioglu","year":"2003","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.survophthal.2005.04.009_bib137","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1442-2042.2002.00468.x","article-title":"Urinary adrenomedullin levels are increased and correlated with plasma concentrations in patients with Beh\u00e7et's syndrome","volume":"9","author":"Evereklioglu","year":"2002","journal-title":"Int J Urol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib138","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1067\/mjd.2002.118338","article-title":"Increased nitric oxide production in patients with Beh\u00e7et's disease: is it a new activity marker?","volume":"46","author":"Evereklioglu","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib139","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0002-9343(99)80382-9","article-title":"Neonatal Beh\u00e7et's disease","volume":"98","author":"Fain","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib140","first-page":"185","article-title":"The treatment of recurrent uveitis with TNF-\u03b1 inhibitors","volume":"56","author":"Falappone","year":"2004","journal-title":"Reumatismo"},{"key":"10.1016\/j.survophthal.2005.04.009_bib141","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/ard.40.5.509","article-title":"Neonatal Beh\u00e7et's syndrome in an infant of a mother with the disease","volume":"40","author":"Fam","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib142","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jnnp.64.3.382","article-title":"Beh\u00e7et's syndrome: a report of 41 patients with emphasis on neurological manifestations","volume":"64","author":"Farah","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.survophthal.2005.04.009_bib143","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/ard.55.1.7","article-title":"Nitric oxide","volume":"55","author":"Farrell","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib144","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1515\/CCLM.2004.263","article-title":"Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Beh\u00e7et's disease","volume":"42","author":"Feki","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib145","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(94)92549-6","article-title":"Interferon-\u03b1 2b for refractory ocular Beh\u00e7et's disease","volume":"343","author":"Feron","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2005.04.009_bib146","first-page":"1365","article-title":"Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases","volume":"129","author":"Fontes","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib147","series-title":"Ophthalmology","first-page":"1","article-title":"General approach to uveitis patient and treatment strategies","author":"Forster","year":"1999"},{"key":"10.1016\/j.survophthal.2005.04.009_bib148","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z","article-title":"Th1 polarization of the immune response in Beh\u00e7et's disease: a putative pathogenic role of interleukin-12","volume":"42","author":"Frassanito","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib149","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/ard.52.8.619","article-title":"Effect of surgical cleaning of the skin on the pathergy phenomenon in Beh\u00e7et's syndrome","volume":"52","author":"Fresko","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib150","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2249.1999.01069.x","article-title":"\u03b3 \u03b4 T cells in Beh\u00e7et's disease (BD) and recurrent aphthous stomatitis (RAS)","volume":"118","author":"Freysdottir","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib151","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0021-5155(99)00025-8","article-title":"Cyclosporin microemulsion preconcentrate treatment of patients with Beh\u00e7et's disease","volume":"43","author":"Fujino","year":"1999","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib152","first-page":"335","article-title":"Granulocyte-apheresis in ocular Beh\u00e7et's disease resistant to medical treatment","volume":"79","author":"Garcia Garcia","year":"2004","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib153","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0039-6257(97)00026-X","article-title":"Ocular immunopathology of Beh\u00e7et's disease","volume":"42","author":"George","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib154","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-2796.1998.00159.x","article-title":"Efficacy and safety of systemic recombinant interferon-alpha in Beh\u00e7et's disease","volume":"243","author":"Georgiou","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(99)70523-2","article-title":"Beh\u00e7et's disease and complex aphthosis","volume":"40","author":"Ghate","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib156","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/112067210401400515","article-title":"Infliximab for the treatment of posterior uveitis with retinal neovascularization in Beh\u00e7et disease","volume":"14","author":"Giansanti","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib157","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00045391-200209000-00015","article-title":"Current therapy for Beh\u00e7et's disease","volume":"9","author":"G\u00f6ker","year":"2002","journal-title":"Am J Ther"},{"key":"10.1016\/j.survophthal.2005.04.009_bib158","series-title":"Ophthalmology","first-page":"1","article-title":"Ocular inflammatory and steroid-induced glaucoma","author":"Goldberg","year":"1999"},{"key":"10.1016\/j.survophthal.2005.04.009_bib159","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1034\/j.1399-0039.1999.540309.x","article-title":"Lack of association of MICA transmembrane region polymorphism and Beh\u00e7et's disease in Spain","volume":"54","author":"Gonzalez-Escribano","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.survophthal.2005.04.009_bib160","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/ard.60.6.637","article-title":"Remission of Beh\u00e7et's syndrome with tumor necrosis factor \u03b1 blocking therapy","volume":"60","author":"Goossens","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib161","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/pmj.79.929.127","article-title":"Thalidomide and its derivatives: emerging from the wilderness","volume":"79","author":"Gordon","year":"2003","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.survophthal.2005.04.009_bib162","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/eye.1998.203","article-title":"The role of azathioprine in the management of retinal vasculitis","volume":"12","author":"Greenwood","year":"1998","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2005.04.009_bib163","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1091\/mbc.9.4.875","article-title":"Synthesis, storage, and release of vascular endothelial growth factor\/vascular permeability factor (VEGF\/VGF) by human mast cells: implications for the biological significance of VEGF206","volume":"9","author":"Grutzkau","year":"1998","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.survophthal.2005.04.009_bib164","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000047979","article-title":"Paroxysmal focal dystonia in neuro-Beh\u00e7et by a small ipsilateral thalamic lesion","volume":"47","author":"Guak","year":"2002","journal-title":"Eur Neurol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib165","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0049-3848(97)00063-7","article-title":"Protein S deficiency and antibodies to protein S in patients with Beh\u00e7et's disease","volume":"86","author":"Guermazi","year":"1997","journal-title":"Thromb Res"},{"key":"10.1016\/j.survophthal.2005.04.009_bib166","first-page":"6","article-title":"Beh\u00e7et's disease: an update on the pathogenesis","volume":"19","author":"G\u00fcl","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib167","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/rheumatology\/38.12.1298","article-title":"Procoagulant mutations and venous thrombosis in Beh\u00e7et's disease","volume":"38","author":"G\u00fcl","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib168","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/1529-0131(200111)44:11<2693::AID-ART449>3.0.CO;2-M","article-title":"Linkage mapping of a novel susceptibility locus for Beh\u00e7et's disease to chromosome 6p22\u201323","volume":"44","author":"G\u00fcl","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib169","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/ard.59.8.622","article-title":"Familial aggregation of Beh\u00e7et's disease in Turkey","volume":"59","author":"G\u00fcl","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2474-4-19","article-title":"Remission of Beh\u00e7et's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report","volume":"28","author":"Gulli","year":"2003","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.survophthal.2005.04.009_bib171","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2230.2004.01488.x","article-title":"Erythrocyte superoxide dismutase, catalase activities and plasma nitrite and nitrate levels in patients with Beh\u00e7et disease and recurrent aphthous stomatitis","volume":"29","author":"G\u00fcnd\u00fcz","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib172","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s004080000019","article-title":"Thoracic involvement in Beh\u00e7et's disease and its correlation with multiple parameters","volume":"178","author":"G\u00fcnen","year":"2000","journal-title":"Lung"},{"key":"10.1016\/j.survophthal.2005.04.009_bib173","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00001721-200302000-00001","article-title":"Factor V Leiden mutation and PAI-1 gene 4G\/5G genotype in thrombotic patients with Beh\u00e7et's disease","volume":"14","author":"Gurgey","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib174","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3349\/ymj.1997.38.6.423","article-title":"Clinical manifestations of Beh\u00e7et's disease: an analysis of 2147 patients","volume":"38","author":"G\u00fcrler","year":"1997","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.survophthal.2005.04.009_bib175","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1259\/bjr\/45993201","article-title":"Endovascular management of multiple arterial aneurysms in Beh\u00e7et's disease","volume":"77","author":"Hama","year":"2004","journal-title":"Br J Radiol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib176","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0038-1646409","article-title":"Coagulation and fibrinolytic activity in Beh\u00e7et's disease","volume":"66","author":"Hampton","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.survophthal.2005.04.009_bib177","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.amjmed.2004.05.027","article-title":"Pulmonary artery aneurysms in Beh\u00e7et syndrome","volume":"117","author":"Hamuryudan","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib178","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Beh\u00e7et's syndrome: a randomized, double-blind, placebo-controlled trial","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib179","first-page":"1098","article-title":"Systemic interferon \u03b1-2b treatment in Beh\u00e7et's syndrome","volume":"21","author":"Hamuryudan","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib180","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","article-title":"Azathioprine in Beh\u00e7et's syndrome: effects on long-term prognosis","volume":"40","author":"Hamuryudan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib181","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/rheumatology\/33.1.48","article-title":"Pulmonary artery aneurysms in Beh\u00e7et's syndrome: a report of 24 cases","volume":"33","author":"Hamuryudan","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib182","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/030097402320318387","article-title":"Cytokine profile in Beh\u00e7et's disease patients. Relationship with disease activity","volume":"31","author":"Hamzaoui","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib183","first-page":"2301","article-title":"Phenotype and functional profile of T cells expressing \u03b3\u03b4 receptor from patients with active Beh\u00e7et's disease","volume":"21","author":"Hamzaoui","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib184","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/09629359990595","article-title":"Expression of Bcl-2 in inflammatory sites from patients with active Beh\u00e7et's disease","volume":"8","author":"Hamzaoui","year":"1999","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.survophthal.2005.04.009_bib185","doi-asserted-by":"crossref","unstructured":"Han SW, Kim GW, Lee J, et al: Successful treatment with stent angioplasty for Budd-Chiari syndrome in Beh\u00e7et's disease. Rheumatol Int 25:234\u20137, 2005","DOI":"10.1007\/s00296-004-0495-4"},{"key":"10.1016\/j.survophthal.2005.04.009_bib186","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(98)11058-9","article-title":"Homocysteine and vascular disease","volume":"354","author":"Hankey","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2005.04.009_bib187","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0720-048X(03)00006-8","article-title":"Fibrosing mediastinitis and thrombosis of superior vena cava associated with Beh\u00e7et's disease","volume":"48","author":"Harman","year":"2003","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib188","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1084\/jem.187.11.1885","article-title":"Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytoxic responses in the CD8+ subset","volume":"187","author":"Haslett","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib189","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1053\/gast.2001.22556","article-title":"Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Beh\u00e7et's disease: a case report","volume":"120","author":"Hassard","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib190","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1297-319X(02)00418-9","article-title":"Vascular involvement in Beh\u00e7et's disease. Two case reports","volume":"69","author":"Hassikou","year":"2002","journal-title":"Jone Bone Spine"},{"key":"10.1016\/j.survophthal.2005.04.009_bib191","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/ard.2003.017467","article-title":"The pustular skin lesions in Beh\u00e7et's syndrome are not sterile","volume":"63","author":"Hatemi","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib192","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/ard.2003.010975","article-title":"Successful treatment of genital ulcers with infliximab in Beh\u00e7et's disease","volume":"63","author":"Haugeberg","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib193","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2559.2004.01954.x","article-title":"Neutrophilic phlebitis is characteristic of intestinal Beh\u00e7et's disease and simple ulcer syndrome","volume":"45","author":"Hayasaki","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib194","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.59.1.61","article-title":"Selectin adhesion molecules in Beh\u00e7et's disease","volume":"59","author":"Haznedaroglu","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000040847","article-title":"Haemostasis, thrombosis, and endothelium in Beh\u00e7et's disease","volume":"99","author":"Haznedaroglu","year":"1998","journal-title":"Acta Haematol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib196","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0609.1996.tb00499.x","article-title":"Haemostatic markers of procoagulant imbalance in Beh\u00e7et's disease","volume":"57","author":"Haznedaroglu","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib197","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/clim.2000.4901","article-title":"Immunopathogenesis of Beh\u00e7et's disease","volume":"96","author":"Hegab","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib198","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/rheumatology\/36.6.696","article-title":"IgA nephropathy in a patient with Beh\u00e7et's syndrome: case report and review of literature","volume":"36","author":"Hemmen","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib199","first-page":"565","article-title":"Criteria for diagnosis of Beh\u00e7et's syndrome","volume":"76","author":"Hewitt","year":"1969","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"10.1016\/j.survophthal.2005.04.009_bib200","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/clin.1996.4268","article-title":"Cerebrospinal fluid interleukin-6 in progressive Neuro-Beh\u00e7et's syndrome","volume":"82","author":"Hirohata","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib201","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-510X(98)00165-8","article-title":"Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Beh\u00e7et's disease","volume":"159","author":"Hirohata","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.survophthal.2005.04.009_bib202","first-page":"244","article-title":"Prevalence of Beh\u00e7et's syndrome in Hawaii. With particular reference to the comparison of the Japanese in Hawaii and Japan","volume":"34","author":"Hirohata","year":"1975","journal-title":"Hawaii Med J"},{"key":"10.1016\/j.survophthal.2005.04.009_bib203","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1148\/rg.243035091","article-title":"Thoracic manifestations of Beh\u00e7et disease at CT","volume":"24","author":"Hiller","year":"2004","journal-title":"Radiographics"},{"key":"10.1016\/j.survophthal.2005.04.009_bib204","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0090-1229(92)90042-M","article-title":"Interleukin-6 and its relation to inflammation and disease","volume":"62","author":"Hirano","year":"1992","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib205","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0008-8749(92)90207-6","article-title":"Streptococcal-related antigens stimulate production of IL-6 and interferon-\u03b3 by T cells from patients with Beh\u00e7et's disease","volume":"140","author":"Hirohata","year":"1992","journal-title":"Cell Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib206","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaut.2004.07.005","article-title":"Abnormal expression of chemokine receptors in Beh\u00e7et's disease: relationship to intracellular Th1\/Th2 cytokines and to clinical manifestations","volume":"23","author":"Houman","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1016\/j.survophthal.2005.04.009_bib207","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/09629350400003167","article-title":"Tc1\/Tc2 ratio in the inflammatory process in patients with Beh\u00e7et's disease","volume":"13","author":"Houman","year":"2004","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.survophthal.2005.04.009_bib208","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2444::AID-IMMU2444>3.0.CO;2-N","article-title":"Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351","volume":"28","author":"Hu","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib209","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2990.2003.00499.x","article-title":"The pathology and pathogenesis of retinal vasculitis","volume":"29","author":"Hughes","year":"2003","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib210","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/bjo.82.5.498","article-title":"Plasma endothelin-1 concentrations in patients with retinal vein occlusions","volume":"82","author":"Iannaccone","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib211","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1076\/opep.9.5.325.10338","article-title":"The prevalence of Beh\u00e7et's disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey","volume":"9","author":"Idil","year":"2002","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib212","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/01.CIR.99.9.1230","article-title":"Homocysteine increases nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells","volume":"99","author":"Ikeda","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.survophthal.2005.04.009_bib213","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2249.2005.02695.x","article-title":"Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Beh\u00e7et's disease","volume":"139","author":"Imamura","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib214","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1468-3083.2004.00547.x","article-title":"The significance of immunohistochemistry in the skin pathergy reaction of patients with Beh\u00e7et's syndrome","volume":"18","author":"Inal\u00f6z","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib215","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et's Disease: Criteria for diagnosis of Beh\u00e7et's disease","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2005.04.009_bib216","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jvs.2004.09.018","article-title":"Compelling nature of arterial manifestations in Beh\u00e7et disease","volume":"41","author":"Iscan","year":"2005","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.survophthal.2005.04.009_bib217","first-page":"233","article-title":"Low dose weekly methotrexate therapy for progressive neuro-Beh\u00e7et's syndrome: a follow up study for 36 months","volume":"41","author":"Ishi","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib218","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0899-7071(03)00284-5","article-title":"Serial MRI findings in a relapsing-remitting form of neuro-Beh\u00e7et's disease: a case report","volume":"28","author":"Ishida","year":"2004","journal-title":"Clin Imaging"},{"key":"10.1016\/j.survophthal.2005.04.009_bib219","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0190-9622(94)70102-4","article-title":"Beh\u00e7et's disease in South African blacks: report of five cases","volume":"30","author":"Jacyk","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib220","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0161-6420(03)00406-8","article-title":"Infliximab in the treatment of refractory posterior uveitis","volume":"110","author":"Joseph","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib221","first-page":"55","article-title":"\u03b3 \u03b4 T cells, their T cell receptor usage and role in human diseases","volume":"21","author":"Kabelitz","year":"1999","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib222","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/sarh.2001.19819","article-title":"Treatment of Beh\u00e7et's disease: an update","volume":"30","author":"Kaklamani","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib223","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0049-0172(98)80001-2","article-title":"Beh\u00e7et's Disease","volume":"27","author":"Kaklamani","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib224","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0022-5347(05)67908-6","article-title":"Recurrent epididymoorchitis in patients with Beh\u00e7et's disease","volume":"163","author":"Kaklamani","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib225","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3349\/ymj.1997.38.6.444","article-title":"Streptococcal infection in the pathogenesis of Beh\u00e7et's disease and clinical effects of minocycline on the disease symptoms","volume":"38","author":"Kaneko","year":"1997","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.survophthal.2005.04.009_bib226","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2249.1997.3611265.x","article-title":"Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Beh\u00e7et's disease (BD) in Japan","volume":"108","author":"Kaneko","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib227","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jaad.2003.12.023","article-title":"Treatment of Beh\u00e7et's disease with granulocyte and monocyte adsorption apheresis","volume":"51","author":"Kanekura","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib228","series-title":"Uveitis. Clinical ophthalmology, a systematic approach","author":"Kanski","year":"2003"},{"key":"10.1016\/j.survophthal.2005.04.009_bib229","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ajo.2004.02.053","article-title":"Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Beh\u00e7et disease","volume":"138","author":"Kara\u00e7orlu","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib230","doi-asserted-by":"crossref","unstructured":"Karasneh JA, Hajeer AH, Silman A, et al: Polymorphisms in the endothelial nitric oxide synthase gene are associated with Beh\u00e7et's disease. Rheumatology 44:614\u20137, 2005","DOI":"10.1093\/rheumatology\/keh561"},{"key":"10.1016\/j.survophthal.2005.04.009_bib231","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/rheumatology\/40.8.933","article-title":"Beh\u00e7et's disease in UK children: clinical features and treatment including thalidomide","volume":"40","author":"Kari","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib232","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1468-3083.2003.00760.x","article-title":"Stressful life events, anxiety, depression and coping mechanisms in patients with Beh\u00e7et's disease","volume":"17","author":"Karlidag","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib233","series-title":"Arthritis and allied conditions","first-page":"1291","article-title":"Beh\u00e7et's disease","author":"Kastner","year":"1997"},{"key":"10.1016\/j.survophthal.2005.04.009_bib234","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/0-306-48382-3_111","article-title":"Successful long-term treatment of refractory Adamantiades-Beh\u00e7et's disease (ABD) with infliximab: report of two patients","volume":"528","author":"Katsiari","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib235","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1046\/j.1365-2230.2002.01060.x","article-title":"Association of class I HLA antigens with the clinical manifestations of Turkish patients with Beh\u00e7et's disease","volume":"27","author":"Kaya","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib236","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9394(00)00498-0","article-title":"Clonally accumulating T cells in the anterior chamber of Beh\u00e7et disease","volume":"130","author":"Keino","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib237","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1034\/j.1399-0039.1999.540605.x","article-title":"Significant association of HLA-B\u22175101 and B\u22175108, and lack of association of class II alleles with Beh\u00e7et's disease in Italian patients","volume":"54","author":"Kera","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.survophthal.2005.04.009_bib238","first-page":"59","article-title":"T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Beh\u00e7et's disease","volume":"22","author":"Kibaroglu","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib239","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/brain\/122.11.2183","article-title":"Neurological complications in Beh\u00e7et's syndrome","volume":"122","author":"Kidd","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2005.04.009_bib240","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000372-200010000-00001","article-title":"Histopathologic features of erythema nodosum-like lesions in Beh\u00e7et disease: a comparison with erythema nodosum focusing on the role of vasculitis","volume":"22","author":"Kim","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib241","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0886-3350(02)01356-1","article-title":"Opacification of a hydrophilic acrylic intraocular lens with exacerbation of Beh\u00e7et's uveitis","volume":"28","author":"Kim","year":"2002","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.survophthal.2005.04.009_bib242","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3346\/jkms.2003.18.3.415","article-title":"Intercellular adhesion molecule-1 polymorphism in Korean patients with Beh\u00e7et's disease","volume":"18","author":"Kim","year":"2003","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.survophthal.2005.04.009_bib243","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/03009749709115831","article-title":"Arthropathy in Beh\u00e7et's disease","volume":"26","author":"Kim","year":"1997","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib244","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/ard.62.11.1083","article-title":"Endothelial nitric oxide synthase gene polymorphisms in Beh\u00e7et's disease and rheumatic diseases with vasculitis","volume":"62","author":"Kim","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib245","first-page":"71","article-title":"Parvovirus B19 infection in Beh\u00e7et's disease","volume":"14","author":"Kiraz","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib246","first-page":"25","article-title":"Interactions of nitric oxide and superoxide dismutase in Beh\u00e7et's disease","volume":"19","author":"Kiraz","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib247","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0049-3848(02)00006-3","article-title":"Pathological haemostasis and \u201cprothrombotic state\u201d in Beh\u00e7et's disease","volume":"105","author":"Kiraz","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.survophthal.2005.04.009_bib248","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/clin.1996.0181","article-title":"Thalidomide as an anti-TNF-\u03b1 inhibitor: implications for clinical use","volume":"81","author":"Klausner","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib249","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2559.2000.00859.x","article-title":"Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Beh\u00e7et disease","volume":"36","author":"Kobayashi","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib250","first-page":"1015","article-title":"CNS involvement in neuro-Beh\u00e7et syndrome: an MR study","volume":"20","author":"Ko\u00e7er","year":"1999","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib251","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1378\/chest.104.1.309","article-title":"Pulmonary infiltrates recovered by FK506 in a patient with Beh\u00e7et's disease","volume":"104","author":"Koga","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.survophthal.2005.04.009_bib252","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0009-9120(02)00400-9","article-title":"Effects of vitamin E supplementation on blood antioxidants levels in patients with Beh\u00e7et's disease","volume":"35","author":"K\u00f6k\u00e7am","year":"2002","journal-title":"Clin Biochem"},{"key":"10.1016\/j.survophthal.2005.04.009_bib253","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-3476(99)70333-1","article-title":"Familial aggregation in Beh\u00e7et's disease: high frequency in siblings and parents of pediatric probands","volume":"135","author":"Kone-Paut","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.survophthal.2005.04.009_bib254","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0022-3476(98)70368-3","article-title":"Clinical features of Beh\u00e7et's disease in children. an international collaborative study of 86 cases","volume":"132","author":"Kone-Paut","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.survophthal.2005.04.009_bib255","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00261-002-0036-0","article-title":"Enteroclysis findings of intestinal Beh\u00e7et's disease: a comparative study with Chron disease","volume":"28","author":"Korman","year":"2003","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.survophthal.2005.04.009_bib256","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1254\/jjp.75.253","article-title":"In vitro antioxidant effect of Ginkgo biloba extract (EGb 761) on lipoperoxidation induced by hydrogen peroxide in erythrocytes of Beh\u00e7et's patients","volume":"75","author":"K\u00f6se","year":"1997","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib257","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0009-9120(01)00190-4","article-title":"The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Beh\u00e7et's disease","volume":"34","author":"K\u00f6se","year":"2001","journal-title":"Clin Biochem"},{"key":"10.1016\/j.survophthal.2005.04.009_bib258","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1620\/tjem.197.9","article-title":"Lipid peroxidation and erythrocyte antioxidant enzymes in patients with Beh\u00e7et's disease","volume":"197","author":"K\u00f6se","year":"2002","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib259","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0161-6420(99)90120-3","article-title":"Central nervous system symptoms in patients with Beh\u00e7et's disease receiving cyclosporine therapy","volume":"106","author":"Kotake","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib260","first-page":"113","article-title":"Erosive arthritis and posterior uveitis in Beh\u00e7et's disease. Treatment with interferon \u03b1 and interferon \u03b3","volume":"14","author":"K\u00f6tter","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib261","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/bjo.82.5.488","article-title":"Treatment of ocular symptoms of Beh\u00e7et's disease with interferon-\u03b12a: a pilot study","volume":"82","author":"K\u00f6tter","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib262","first-page":"133","article-title":"Beh\u00e7et's disease in patients of German and Turkish origin living in Germany: a comparative analysis","volume":"31","author":"K\u00f6tter","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib263","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semarthrit.2003.09.005","article-title":"Differential efficacy of human recombinant interferon-\u03b12a on ocular and extraocular manifestations of Beh\u00e7et disease: results of an open 4-center trial","volume":"33","author":"K\u00f6tter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib264","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bjo.87.4.423","article-title":"Human recombinant interferon alfa-2a for the treatment of Beh\u00e7et's disease with sight threatening posterior or panuveitis","volume":"87","author":"K\u00f6tter","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib265","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10350-004-6506-4","article-title":"Beh\u00e7et's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case","volume":"46","author":"Kram","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib266","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ajo.2004.04.064","article-title":"Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Beh\u00e7et's disease","volume":"138","author":"Kramer","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib267","first-page":"21","article-title":"Anti-Saccharomyces cerevisiae antibodies\u2014a novel serologic marker for Beh\u00e7et's disease","volume":"20","author":"Krause","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib268","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00417-003-0754-1","article-title":"Vitrectomy and trabeculectomy combined with interferon alpha treatment in Adamantiades-Beh\u00e7et's disease: a case report","volume":"241","author":"Krause","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib269","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","article-title":"The long-term mortality and morbidity of Beh\u00e7et's syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center","volume":"82","author":"Kural-Seyahi","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.survophthal.2005.04.009_bib270","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1365-2249.2000.01176.x","article-title":"Anti-MHC autoimmunity in Beh\u00e7et's disease: T cell responses to an HLA-B derived peptide cross-reactive with retinal-S antigen in patients with uveitis","volume":"120","author":"Kurhan-Yavuz","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib271","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s10067-004-0897-4","article-title":"Neuro- Beh\u00e7et's disease with chorea after remission of intestinal Beh\u00e7et's disease","volume":"23","author":"Kuriwaka","year":"2004","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib272","series-title":"Ophthalmology","first-page":"1","article-title":"Beh\u00e7et's syndrome","author":"Kurumety","year":"1999"},{"key":"10.1016\/j.survophthal.2005.04.009_bib273","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00296-003-0327-y","article-title":"Development of amyloidosis in Beh\u00e7et's syndrome with isolated mucocutaneous involvement","volume":"24","author":"Kutlay","year":"2004","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.survophthal.2005.04.009_bib274","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/rheumatology\/keg453","article-title":"The Beh\u00e7et's disease activity index","volume":"43","author":"Lawton","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib275","first-page":"423","article-title":"Pentoxifylline inhibits perforin-dependent natural cytotoxicity in vitro","volume":"9","author":"Lazarczyk","year":"2002","journal-title":"Oncol Rep"},{"key":"10.1016\/j.survophthal.2005.04.009_bib276","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/art.11074","article-title":"Human \u03b1-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Beh\u00e7et's disease","volume":"48","author":"Lee","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib277","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/sder.2001.23097","article-title":"Beh\u00e7et's disease","volume":"20","author":"Lee","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.survophthal.2005.04.009_bib278","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF02505221","article-title":"Polymerase chain reaction reveals Herpes simplex virus DNA in saliva of patients with Beh\u00e7et's disease","volume":"288","author":"Lee","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.survophthal.2005.04.009_bib279","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0049-3848(02)00085-3","article-title":"Coagulation parameters and plasma total homocysteine levels in Beh\u00e7et's disease","volume":"106","author":"Lee","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.survophthal.2005.04.009_bib280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/08830189709116842","article-title":"The role of heat shock protein, microbial and autoimmune agents in the aetiology of Beh\u00e7et's disease","volume":"14","author":"Lehner","year":"1997","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib281","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1128\/iai.59.4.1434-1441.1991","article-title":"Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Beh\u00e7et's syndrome","volume":"59","author":"Lehner","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.survophthal.2005.04.009_bib282","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/ard.2003.014241","article-title":"Thrombophilic factors are not the leading cause of thrombosis in Beh\u00e7et's disease","volume":"63","author":"Leiba","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib283","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/bjo.87.10.1264","article-title":"T-bet expression is upregulated in active Beh\u00e7et's disease","volume":"87","author":"Li","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib284","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/ard.62.3.280","article-title":"Anti-tumour necrosis factor \u03b1 monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Beh\u00e7et's syndrome","volume":"62","author":"Licata","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib285","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/rheumatology\/keg424","article-title":"Remission induction in Beh\u00e7et's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H","volume":"42","author":"Lockwood","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib286","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev.med.51.1.207","article-title":"Anti-cytokine therapy for rheumatoid arthritis","volume":"51","author":"Maini","year":"2000","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib287","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ophtha.2003.10.012","article-title":"Infliximab treatment of posterior uveitis","volume":"111","author":"Mansour","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib288","first-page":"510","article-title":"Serum levels of Th2 cytokines IL-4 and IL-10 in Beh\u00e7et's disease","volume":"26","author":"Manta\u015f","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib289","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2370.2004.00446.x","article-title":"MICA polymorphism in a sample of the Sao Paulo population, Brazil","volume":"31","author":"Marin","year":"2004","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.survophthal.2005.04.009_bib290","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ajo.2004.04.066","article-title":"Infliximab for chronic cystoid macular edema associated with uveitis","volume":"138","author":"Markomichelakis","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib291","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/rheumatology\/36.2.234","article-title":"Beh\u00e7et's disease and pregnancy relationship study","volume":"36","author":"Marsal","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib292","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.berh.2004.02.008","article-title":"Beh\u00e7et's disease","volume":"18","author":"Marshall","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib293","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/ard.28.2.95","article-title":"Beh\u00e7et's syndrome with arthritis","volume":"28","author":"Mason","year":"1969","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib294","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","article-title":"Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Beh\u00e7et's disease","volume":"1","author":"Masuda","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2005.04.009_bib295","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.4049\/jimmunol.162.7.4328","article-title":"Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases","volume":"162","author":"Matsui","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib296","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/1529-0131(200102)44:2<384::AID-ANR57>3.0.CO;2-Z","article-title":"Detection of autoantibodies to killer immunoglobulin-like receptors using recombinant fusion proteins for two killer immunoglobulin-like receptors in patients with systemic autoimmune diseases","volume":"44","author":"Matsui","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib297","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000050854","article-title":"Ocular attacks after phacoemulsification and intraocular lens in patients with Beh\u00e7et disease","volume":"215","author":"Matsuo","year":"2001","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.survophthal.2005.04.009_bib298","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/1523-1747.ep12605702","article-title":"Heat shock proteins and molecular chaperones: implications for adaptive responses in the skin","volume":"104","author":"Maytin","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib299","first-page":"1544","article-title":"Overproduction of monocyte derived tumor necrosis factor \u03b1, interleukin (IL)-6, IL-8 and increased neutrophil superoxide generation in Beh\u00e7et's disease: a comparative study with familial Mediterranean fever and healthy subjects","volume":"20","author":"Mege","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib300","doi-asserted-by":"crossref","unstructured":"Melikoglu M, Altiparmak MR, Fresko I, et al: A reappraisal of amyloidoss in Beh\u00e7et's syndrome. Rheumatology (Oxford) 40:212\u20135, 2001","DOI":"10.1093\/rheumatology\/40.2.212"},{"key":"10.1016\/j.survophthal.2005.04.009_bib301","first-page":"98","article-title":"Short-term trial of etanercept in Beh\u00e7et's disease: a double blind, placebo controlled study","volume":"32","author":"Melikoglu","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib302","first-page":"181","article-title":"The response of treatment resistant uveitis in Beh\u00e7et's syndrome (BS) to a TNF-\u03b1 blocker, etanercept: an open study","volume":"46","author":"Melikoglu","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib303","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0039-6257(82)90079-0","article-title":"Beh\u00e7et's disease","volume":"26","author":"Michelson","year":"1982","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib304","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/01.WNL.0000130192.12100.8D","article-title":"Neuro-Beh\u00e7et disease with predominant involvement of the brainstem","volume":"27","author":"Mirsattari","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib305","doi-asserted-by":"crossref","unstructured":"Mishima H, Masuda K, Shimada S, et al: Plasminogen activator activity in patients with Beh\u00e7et's sydrome. Arch Ophthalmol 103:935\u20136, 1985","DOI":"10.1001\/archopht.1985.01050070061030"},{"key":"10.1016\/j.survophthal.2005.04.009_bib306","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cyto.2003.09.003","article-title":"Cytokine production profile in patients with Beh\u00e7et's disease treated with infliximab","volume":"24","author":"Misumi","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.survophthal.2005.04.009_bib307","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/08830189709116843","article-title":"Pathogenic gene responsible for the predisposition of Beh\u00e7et's disease","volume":"14","author":"Mizuki","year":"1997","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib308","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1073\/pnas.94.4.1298","article-title":"Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Beh\u00e7et's disease","volume":"94","author":"Mizuki","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.survophthal.2005.04.009_bib309","first-page":"32","article-title":"Beh\u00e7et's disease","volume":"3","author":"Mizushima","year":"1991","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib310","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/08830189709116844","article-title":"Immunotherapy for Beh\u00e7et's disease","volume":"14","author":"Mochizuki","year":"1997","journal-title":"Intern Rev Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib311","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0002-9394(14)73645-1","article-title":"A clinical trial of FK506 in refractory uveitis","volume":"115","author":"Mochizuki","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib312","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/eji.1830240712","article-title":"Fine antigen specificity of human \u03b3 \u03b4 T cell lines (V gamma 9+) established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Streptococcus sanguis","volume":"24","author":"Mochizuki","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib313","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1378\/chest.118.2.479","article-title":"Intracardiac thrombus in Beh\u00e7et's disease: a systematic review","volume":"118","author":"Mogulko\u00e7","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.survophthal.2005.04.009_bib314","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5414\/CNP61357","article-title":"Renal transplantation in a C-ANCA(+) patient with Beh\u00e7et disease and rapidly progressive glomerulonephritis","volume":"61","author":"Moises","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib315","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0091-6749(00)90084-8","article-title":"Chemokine- and cytokine-induced expression of endothelin 1 and endothelin-converting enzyme 1 in endothelial cells","volume":"105","author":"Molet","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib316","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ajmg.a.20136","article-title":"Identification of an autosomal recessive mode of inheritance in paediatric Beh\u00e7et's families by segregation analysis","volume":"122","author":"Molinari","year":"2003","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.survophthal.2005.04.009_bib317","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2004.02.021","article-title":"Cognitive impairment in Beh\u00e7et's disease patients without overt neurological involvement","volume":"220","author":"Monastero","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.survophthal.2005.04.009_bib318","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/1521-4141(200202)32:2<356::AID-IMMU356>3.0.CO;2-9","article-title":"Identification of \u03b1-tropomyosin as a target self-antigen in Beh\u00e7et's syndrome","volume":"32","author":"Mor","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib319","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","article-title":"Thalidomide exerts its inhibitory action on tumor necrosis factor \u03b1 by enhancing mRNA degradation","volume":"177","author":"Moreira","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib320","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1159\/000177401","article-title":"Cardiac involvement in Beh\u00e7et's disease","volume":"88","author":"Morelli","year":"1997","journal-title":"Cardiology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib321","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0741-5214(03)00941-8","article-title":"Inferior mesenteric artery aneurysm in Beh\u00e7et syndrome","volume":"38","author":"Morimoto","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.survophthal.2005.04.009_bib322","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/0-306-48382-3_112","article-title":"The effect of anti-tumour necrosis factor \u03b1 (infliximab) on sight-threatening uveitis in a patient with Beh\u00e7et's disease","volume":"528","author":"Morris","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib323","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000116956","article-title":"Magnetic resonance imaging of the central nervous system in Beh\u00e7et's disease","volume":"33","author":"Morrissey","year":"1993","journal-title":"Eur Neurol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib324","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2168.2001.01743.x","article-title":"Leptin and its relation to weight loss, ob gene expression and the acute-phase response in surgical patients","volume":"88","author":"Moses","year":"2001","journal-title":"Br J Surg"},{"key":"10.1016\/j.survophthal.2005.04.009_bib325","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/clinchem\/43.4.553","article-title":"Nitric oxide determinations: Much ado about NO-thing?","volume":"43","author":"Moshage","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.survophthal.2005.04.009_bib326","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1076\/ocii.9.4.219.3957","article-title":"Short-term chlorambucil for refractory uveitis in Beh\u00e7et's disease","volume":"9","author":"Mudun","year":"2001","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2005.04.009_bib327","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-0714.2004.00265.x","article-title":"Clinical and immunological effects of azithromycin in Beh\u00e7et's disease","volume":"34","author":"Mumcu","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib328","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(01)06677-6","article-title":"Effect of infliximab on threatening panuveitis in Beh\u00e7et's disease","volume":"358","author":"Munoz-Fernandez","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2005.04.009_bib329","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1572-0241.2003.07317.x","article-title":"Successful treatment of cervical esophageal perforation in Beh\u00e7et's disease with drainage operation and infliximab","volume":"98","author":"Mussack","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib330","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2249.2004.02688.x","article-title":"Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Beh\u00e7et's disease","volume":"139","author":"Nagafuchi","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib331","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1440-1746.2002.02573.x","article-title":"A case of Beh\u00e7et's disease accompanied by colitis with longitudinal ulcers and granuloma","volume":"17","author":"Naganuma","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib332","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2141.2004.05072.x","article-title":"Activated protein C levels in Beh\u00e7et's disease and risk of venous thrombosis","volume":"126","author":"Navarro","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib333","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor (VEGF) and its receptors","volume":"13","author":"Neufeld","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.survophthal.2005.04.009_bib334","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00041327-200106000-00011","article-title":"Interferon-a2a treatment of neuro-Beh\u00e7et's disease","volume":"21","author":"Nichols","year":"2001","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib335","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jdermsci.2003.12.004","article-title":"Lack of association of interleukin-12 p40 gene (IL12B) polymorphism with Beh\u00e7et 's disease in the Japanese population","volume":"34","author":"Nishida","year":"2004","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.survophthal.2005.04.009_bib336","first-page":"255","article-title":"Familial occurrence of Beh\u00e7et's disease","volume":"40","author":"Nishiura","year":"1996","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib337","first-page":"743","article-title":"A study among related pairs of Japanese patients with familial Beh\u00e7et's disease: group comparisons by interval of disease onsets","volume":"29","author":"Nishiyama","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib338","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0021-5155(01)00321-5","article-title":"A study of familial occurrence of Beh\u00e7et's disease with and without ocular lesions","volume":"45","author":"Nishiyama","year":"2001","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib339","first-page":"51","article-title":"Use of the highly sensitive PCR method to detect the Herpes simplex virus type 1 genome and its expression in samples from Beh\u00e7et disease patients","volume":"45","author":"Nomura","year":"1998","journal-title":"J Med Dent Sci"},{"key":"10.1016\/j.survophthal.2005.04.009_bib340","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3349\/ymj.2003.44.5.771","article-title":"The serum vitamin C levels in Beh\u00e7et's disease","volume":"44","author":"Noyan","year":"2003","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.survophthal.2005.04.009_bib341","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/08830189709116845","article-title":"Uveitis in Beh\u00e7et's disease","volume":"14","author":"Nussenblatt","year":"1997","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib342","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0002-9394(14)71070-0","article-title":"Treatment of uveitis by oral administration of retinal antigens: results of a phase I\/II randomized masked trial","volume":"123","author":"Nussenblatt","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib343","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1749-6632.1996.tb21140.x","article-title":"Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report","volume":"778","author":"Nussenblatt","year":"1996","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.survophthal.2005.04.009_bib344","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0889-857X(21)01067-X","article-title":"Vasculitis in Beh\u00e7et's disease","volume":"16","author":"O'Duffy","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.survophthal.2005.04.009_bib345","first-page":"1938","article-title":"Interferon \u03b1 treatment of Beh\u00e7et's disease","volume":"25","author":"O'Duffy","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib346","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0002-9343(76)90166-2","article-title":"Neurologic involvement in seven patients with Beh\u00e7et's disease","volume":"61","author":"O'Duffy","year":"1976","journal-title":"Am J Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib347","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0002-9343(84)90753-8","article-title":"Chlorambucil in the treatment of uveitis and meningoencephalitis of Beh\u00e7et's disease","volume":"76","author":"O'Duffy","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib348","first-page":"1362","article-title":"Efficacy, safety and pharmacokinetics of multiple administration of infliximab in Beh\u00e7et's disease with refractory uveoretinitis","volume":"31","author":"Ohno","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib349","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s004150050317","article-title":"Neuropsychological follow-up of 12 patients with neuro-Beh\u00e7et disease","volume":"246","author":"\u00d6ktem-Tanor","year":"1999","journal-title":"J Neurol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib350","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1346-8138.1994.tb01729.x","article-title":"Natural cellular cytotoxicity in Beh\u00e7et's disease","volume":"21","author":"\u00d6nder","year":"1994","journal-title":"J Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib351","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0738-081X(99)00063-2","article-title":"Beh\u00e7et's disease: an enigmatic vasculitis","volume":"17","author":"\u00d6nder","year":"1999","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib352","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1468-3083.2001.00251.x","article-title":"The multiple faces of Beh\u00e7et's disease and its aetiological factors","volume":"15","author":"\u00d6nder","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib353","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000018122","article-title":"Autoantibodies against oxidatively modified low-density lipoprotein in patients with Beh\u00e7et's disease","volume":"198","author":"\u00d6rem","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib354","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0923-1811(97)00613-0","article-title":"Relationship between lipid peroxidation and disease activity in patients with Beh\u00e7et's disease","volume":"16","author":"\u00d6rem","year":"1997","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.survophthal.2005.04.009_bib355","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000018061","article-title":"Decreased nitric oxide production in patients with Beh\u00e7et's disease","volume":"198","author":"\u00d6rem","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib356","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0006-8993(93)91400-M","article-title":"NADPH diaphorase localization and nitric oxide synthase activity in the retina and anterior uvea of the rabbit eye","volume":"610","author":"Osborne","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.survophthal.2005.04.009_bib357","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1086\/302364","article-title":"The critical region for Beh\u00e7et disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping","volume":"64","author":"Ota","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.survophthal.2005.04.009_bib358","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00296-001-0143-1","article-title":"Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Beh\u00e7et's disease: evidence of a prethrombotic state","volume":"21","author":"\u00d6zatli","year":"2002","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.survophthal.2005.04.009_bib359","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.amjcard.2004.04.073","article-title":"Vascular endothelial function and plasma homocysteine levels in Beh\u00e7et's disease","volume":"94","author":"\u00d6zdemir","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib360","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00002281-199909000-00011","article-title":"Vasculopathy, Beh\u00e7et's syndrome, and familial Mediterranean fever","volume":"11","author":"\u00d6zen","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib361","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/03009740310004694","article-title":"Bilateral pulmonary artery aneurysms with protein C and protein S deficiency in a patient with Beh\u00e7et's disease","volume":"33","author":"\u00d6zge","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib362","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2230.2004.01684.x","article-title":"Serum interleukin 18 and tumour necrosis factor-\u03b1 levels are increased in Beh\u00e7et's disease","volume":"30","author":"\u00d6zta\u015f","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib363","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00296-003-0324-1","article-title":"Plasminogen activator inhibitor-1 as a link between pathological fibrinolysis and arthritis of Beh\u00e7et's disease","volume":"24","author":"\u00d6zt\u00fcrk","year":"2004","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.survophthal.2005.04.009_bib364","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/107602960300900312","article-title":"Decreased protein Z concentrations complicating the hypercoagulable state of Beh\u00e7et's disease","volume":"9","author":"\u00d6zt\u00fcrk","year":"2003","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.survophthal.2005.04.009_bib365","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjo.76.4.241","article-title":"Low dose cyclosporin A versus pulsed cyclophosphamide in Beh\u00e7et's syndrome: a single masked trial","volume":"76","author":"\u00d6zyazgan","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib366","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3904\/kjim.1999.14.1.66","article-title":"Clinical analysis of Beh\u00e7et disease: arthritic manifestations in Beh\u00e7et disease may present as seronegative rheumatoid arthritis or palindromic rheumatism","volume":"14","author":"Park","year":"1999","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib367","first-page":"561","article-title":"Magnetic resonance imaging and proton magnetic resonance spectroscopy in neuro- Beh\u00e7et's disease","volume":"22","author":"Park","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib368","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archopht.1994.01090160124032","article-title":"The role of nitric oxide in uveitis","volume":"112","author":"Parks","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib369","first-page":"575","article-title":"MICA gene polymorphism in an Italian paediatric series of juvenile Beh\u00e7et's disease","volume":"10","author":"Picco","year":"2002","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib370","first-page":"169","article-title":"Beh\u00e7et's syndrome","volume":"34","author":"Pickering","year":"2000","journal-title":"J R Coll Physicians Lond"},{"key":"10.1016\/j.survophthal.2005.04.009_bib371","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1399-0039.2004.00280.x","article-title":"HLA class I and class II genotyping in patients with Beh\u00e7et's disease: a regional study of eastern part of Turkey","volume":"64","author":"Pirim","year":"2004","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.survophthal.2005.04.009_bib372","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1163\/156855902320387952","article-title":"Association of the platelet glycoprotein Ia C870T\/G873A gene polymorphism and thrombosis in Beh\u00e7et's patients","volume":"32","author":"Polat","year":"2002","journal-title":"Haematologia"},{"key":"10.1016\/j.survophthal.2005.04.009_bib373","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/bjo.87.7.876","article-title":"Beh\u00e7et's disease in patients of west African and Afro-Caribbean origin","volume":"87","author":"Poon","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib374","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ajo.2003.12.010","article-title":"Endothelial cell activation and hypercoagulability in ocular Beh\u00e7et's disease","volume":"137","author":"Probst","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0039-6257(01)00231-4","article-title":"Hypopyon uveitis","volume":"46","author":"Ramsay","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib376","first-page":"1385","article-title":"Epididymitis in Beh\u00e7et disease","volume":"26","author":"Rapelanoro","year":"1997","journal-title":"Presse Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib377","first-page":"329","article-title":"Divergent cytokine production profile in Beh\u00e7et's disease. Altered Th1\/Th2 cell cytokine pattern","volume":"25","author":"Raziuddin","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib378","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0002-9394(99)80163-9","article-title":"High-dose intravenous pulse methylprednisolone hemisuccinate in acute Beh\u00e7et retinitis","volume":"125","author":"Reed","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib379","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/rheumatology\/40.4.473","article-title":"Treatment of recalcitrant orogenital ulceration of Beh\u00e7et's syndrome with Infliximab","volume":"40","author":"Robertson","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib380","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01543103","article-title":"Biology of human TH1 and TH2 cells","volume":"15","author":"Romagnani","year":"1995","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib381","first-page":"1241","article-title":"Blind insight: eyeing anti-tumor necrosis factor treatment in uveitis associated with Beh\u00e7et's disease","volume":"31","author":"Rosenbaum","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib382","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/ard.61.3.283-a","article-title":"Remission of Beh\u00e7et's syndrome with TNF-a blocking treatment","volume":"61","author":"Rozenbaum","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib383","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1024\/0301-1526.32.2.75","article-title":"Arterial lesions in Beh\u00e7et's disease","volume":"32","author":"Saba","year":"2003","journal-title":"Vasa"},{"key":"10.1016\/j.survophthal.2005.04.009_bib384","series-title":"The Cochrane Library, Issue 3","article-title":"Pharmacotherapy for Beh\u00e7et's syndrome (Cochrane Review)","author":"Saenz","year":"2004"},{"key":"10.1016\/j.survophthal.2005.04.009_bib385","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00296-002-0195-x","article-title":"Trace elements and antioxidant enzymes in Beh\u00e7et's disease","volume":"22","author":"Saglam","year":"2002","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.survophthal.2005.04.009_bib386","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/ard.55.2.128","article-title":"Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Beh\u00e7et's disease","volume":"55","author":"\u015fahin","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib387","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/rheumatology\/35.5.424","article-title":"Monocyte activity in Beh\u00e7et's disease","volume":"35","author":"\u015fahin","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib388","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1081\/JDI-120028549","article-title":"Mild renal injury in Beh\u00e7et's disease","volume":"26","author":"\u015fahin","year":"2004","journal-title":"Ren Fail"},{"key":"10.1016\/j.survophthal.2005.04.009_bib389","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0161-6420(95)31022-6","article-title":"Prognostic factors of vision in patients with Beh\u00e7et's disease","volume":"102","author":"Sakamoto","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib390","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1517\/13543784.9.9.1993","article-title":"Novel approaches to Beh\u00e7et's disease","volume":"9","author":"Sakane","year":"2000","journal-title":"Exp Opin Invest Drugs"},{"key":"10.1016\/j.survophthal.2005.04.009_bib391","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib392","first-page":"535","article-title":"Endothelial nitric oxide synthase gene polymorphisms in Beh\u00e7et's disease","volume":"29","author":"Salvarani","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib393","first-page":"1785","article-title":"Vascular endothelial growth factor gene polymorphisms in Beh\u00e7et's disease","volume":"31","author":"Salvarani","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib394","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1468-3083.2003.t01-1-00574.x","article-title":"Nitric oxide levels in Beh\u00e7et's disease","volume":"17","author":"Sancak","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib395","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1399-0039.1998.tb02955.x","article-title":"HLA-Cw\u22171602: a new susceptibility marker of Beh\u00e7et's disease in southern Spain","volume":"51","author":"Sanz","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.survophthal.2005.04.009_bib396","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1517\/14656566.3.7.845","article-title":"Advances in the treatment of rheumatoid arthritis: old versus new therapies","volume":"3","author":"Saravanan","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.survophthal.2005.04.009_bib397","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10067-004-0982-8","article-title":"Levels of soluble E-selectin in patients with active Beh\u00e7et's disease","volume":"24","author":"Sari","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib398","first-page":"181","article-title":"Successful treatment of long-standing neuro-Beh\u00e7et's disease with infliximab","volume":"32","author":"Sarwar","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib399","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/art.11204","article-title":"Treatment with infliximab for a child with Beh\u00e7et's disease","volume":"49","author":"Saulsbury","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib400","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1034\/j.1600-065X.2000.17706.x","article-title":"The neutrophil as a cellular source of chemokines","volume":"177","author":"Scapini","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.survophthal.2005.04.009_bib401","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1056\/NEJM200012143432418","article-title":"Nicotine patches for aphthous ulcers due to Beh\u00e7et's syndrome","volume":"343","author":"Scheid","year":"2000","journal-title":"New Engl J Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib402","first-page":"273","article-title":"Off-label uses and side effects of infliximab","volume":"3","author":"Scheinfeld","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib403","first-page":"2511","article-title":"Is there a place for large vessel disease in the diagnostic criteria of Beh\u00e7et's disease?","volume":"26","author":"Schirmer","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib404","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1084\/jem.181.1.5","article-title":"The functional role of CD8+ T helper type 2 cells","volume":"181","author":"Seder","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib405","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/bjo.85.11.1287","article-title":"Intravenous immuno globulin therapy for resistant ocular Beh\u00e7et's disease","volume":"85","author":"Seider","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib406","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s002680010282","article-title":"Comparison of coagulation parameters for healthy subjects and Beh\u00e7et disease patients with and without vascular involvement","volume":"24","author":"\u015eeng\u00fcl","year":"2001","journal-title":"World J Surg"},{"key":"10.1016\/j.survophthal.2005.04.009_bib407","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1046\/j.1468-3083.2003.00770.x","article-title":"Serum and skin nitrite levels in patients with Beh\u00e7et's disease","volume":"17","author":"\u015eent\u00fcrk","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib408","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s002960050057","article-title":"Adhesion molecule expression in erythema nodosum-like lesions in Beh\u00e7et's disease. A histopathological and immunohistochemical study","volume":"18","author":"\u015eent\u00fcrk","year":"1998","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.survophthal.2005.04.009_bib409","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s004150050205","article-title":"Beh\u00e7et's disease and the nervous system","volume":"245","author":"Serdaroglu","year":"1998","journal-title":"J Neurol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib410","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ard.61.suppl_2.ii51","article-title":"Beh\u00e7et's disease: a new target for anti-tumour necrosis factor treatment","volume":"61","author":"Sfikakis","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib411","doi-asserted-by":"crossref","first-page":"404","DOI":"10.7326\/0003-4819-140-5-200403020-00025","article-title":"Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Beh\u00e7et disease","volume":"140","author":"Sfikakis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib412","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","article-title":"Effect of infliximab on sight-threatening panuveitis in Beh\u00e7et's disease","volume":"358","author":"Sfikakis","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2005.04.009_bib413","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1346-8138.2002.tb00263.x","article-title":"Dapsone in Beh\u00e7et's disease: a double-blind, placebo-controlled, cross- over study","volume":"29","author":"Sharquie","year":"2002","journal-title":"J Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib414","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1542\/peds.103.6.1295","article-title":"Thalidomide responsiveness in an infant with Beh\u00e7et's syndrome","volume":"103","author":"Shek","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.survophthal.2005.04.009_bib415","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0753-3322(01)00154-8","article-title":"Thalidomide in Beh\u00e7et's disease","volume":"56","author":"Shek","year":"2002","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.survophthal.2005.04.009_bib416","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/112067210201200516","article-title":"Conjunctival ulcer: mucocutaneous or ocular manifestation of Beh\u00e7et's disease? A case report","volume":"12","author":"Shenoy","year":"2002","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib417","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1607-551X(09)70258-X","article-title":"Macular hole in Beh\u00e7et's disease","volume":"20","author":"Sheu","year":"2004","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.survophthal.2005.04.009_bib418","first-page":"291","article-title":"Beh\u00e7et's disease","volume":"18","author":"Shimizu","year":"1974","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib419","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-4362.1991.tb05883.x","article-title":"Treatment of Beh\u00e7et's disease with indomethacin","volume":"30","author":"\u015eim\u015fek","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib420","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00019052-200406000-00017","article-title":"Beh\u00e7et's syndrome and the nervous system","volume":"17","author":"Siva","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib421","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s004150170242","article-title":"Beh\u00e7et's disease: diagnostic and prognostic aspects of neurological involvement","volume":"248","author":"Siva","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib422","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0161-6420(99)90156-2","article-title":"Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine","volume":"106","author":"Sloper","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib423","first-page":"21","article-title":"Beh\u00e7et's disease-like symptoms induced by the Herpes simplex virus in ICR mice","volume":"8","author":"Sohn","year":"1998","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib424","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1346-8138.2004.tb00703.x","article-title":"Examination of the relationship between the hepatitis C virus and Beh\u00e7et's disease","volume":"31","author":"S\u00f6nmezoglu","year":"2004","journal-title":"J Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib425","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/bjo.87.8.1010","article-title":"Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study","volume":"87","author":"Sonoda","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib426","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/archopht.123.2.267","article-title":"Therapeutic neutrophil apheresis in patients with ocular Beh\u00e7et disease","volume":"123","author":"Sonoda","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib427","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s100670070020","article-title":"Smoking and Beh\u00e7et's disease","volume":"19","author":"Soy","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib428","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/A:1022587012611","article-title":"Pars plana vitrectomy in ocular Beh\u00e7et's disease","volume":"24","author":"Soylu","year":"2001","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib429","series-title":"Atlas of clinical ophthalmology","first-page":"1","article-title":"Intraocular inflammation","author":"Spalton","year":"1994"},{"key":"10.1016\/j.survophthal.2005.04.009_bib430","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2249.1994.tb06072.x","article-title":"Heat shock protein peptides reactive in patients with Beh\u00e7et's disease are uveitogenic in Lewis rats","volume":"97","author":"Stanford","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib431","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/rheumatology\/36.6.700","article-title":"Life-threatening transient neonatal Beh\u00e7et's disease","volume":"36","author":"Stark","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib432","first-page":"996","article-title":"Increased frequencies of interleukin-2 and interferon-\u03b3-producing T cells in patients with active Beh\u00e7et's disease","volume":"39","author":"Sugi-Ikai","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2005.04.009_bib433","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1034\/j.1600-0420.1998.760118.x","article-title":"Cyclosporine-A therapy in severe uveitis of Beh\u00e7et's disease","volume":"76","author":"S\u00fcll\u00fc","year":"1998","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.survophthal.2005.04.009_bib434","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000051605","article-title":"Bcl-2 expression in skin pathergy reaction of Beh\u00e7et's disease","volume":"202","author":"S\u00fcll\u00fc","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib435","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/art.1780400622","article-title":"In vivo mechanisms for the inhibition of T lymphocyte activation by long-term therapy with tacrolimus (FK-506): experience in patients with Beh\u00e7et's disease","volume":"40","author":"Suzuki","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib436","first-page":"1311","article-title":"Hypoxia regulates vascular endothelial growth factor receptor KDR\/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells","volume":"37","author":"Takagi","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2005.04.009_bib437","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/art.1780380321","article-title":"Excessive function of peripheral blood neutrophils from patients with Beh\u00e7et's disease and from HLA-B51 transgenic mice","volume":"38","author":"Takeno","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib438","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0021-5155(00)00252-5","article-title":"Molecular biological analysis of retinal and streptococcal heat-shock protein 60","volume":"44","author":"Tanaka","year":"2000","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib439","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1076\/ocii.7.2.69.4018","article-title":"Beh\u00e7et's disease and antibody titers to various heat-shock protein 60s","volume":"7","author":"Tanaka","year":"1999","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2005.04.009_bib440","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000267916","article-title":"Common antigenicity between Yersinia enterocolitica-derived heat-shock protein and the retina, and its role in uveitis","volume":"28","author":"Tanaka","year":"1996","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.survophthal.2005.04.009_bib441","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0021-5155(02)00647-0","article-title":"Health-related quality of life in Beh\u00e7et patients with ocular involvement","volume":"47","author":"Tanriverdi","year":"2003","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib442","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2249.1998.00620.x","article-title":"Humoral immune response to mycobacterial heat shock protein (HSP) 65 in the cerebrospinal fluid of neuro-Beh\u00e7et patients","volume":"113","author":"Ta\u015f\u00e7i","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib443","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jns.2004.02.005","article-title":"Long-latency reflexes in patients with Beh\u00e7et's disease","volume":"220","author":"Tataroglu","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.survophthal.2005.04.009_bib444","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.eye.6700556","article-title":"Heidelberg retina tomograph in ocular Beh\u00e7et's disease","volume":"18","author":"Tekeli","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2005.04.009_bib445","first-page":"506","article-title":"skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Beh\u00e7et's disease: a multicenter study","volume":"16","author":"The Beh\u00e7et's Disease Research Committee of Japan","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib446","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1517\/13543784.10.7.1279","article-title":"Novel therapies in vasculitis","volume":"10","author":"Thomas-Golbanov","year":"2001","journal-title":"Exp Opin Invest Drug"},{"key":"10.1016\/j.survophthal.2005.04.009_bib447","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-2478(99)00071-1","article-title":"Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis","volume":"68","author":"Thurau","year":"1999","journal-title":"Immunol Lett"},{"key":"10.1016\/j.survophthal.2005.04.009_bib448","doi-asserted-by":"crossref","first-page":"718","DOI":"10.4049\/jimmunol.143.2.718","article-title":"The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes","volume":"143","author":"Tocci","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib449","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s005350200139","article-title":"Therapeutic effect of intraarterial prednisolone injection in severe intestinal Beh\u00e7et's disease","volume":"37","author":"Toda","year":"2002","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib450","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1297-319X(03)00076-9","article-title":"Vascular manifestations of Beh\u00e7et's disease. Eighteen cases among 140 patients","volume":"70","author":"Tohme","year":"2003","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.survophthal.2005.04.009_bib451","first-page":"118","article-title":"Neurologic manifestations in Beh\u00e7et's disease. 16 cases in a cohort of 110 patients","volume":"148","author":"Tohme","year":"1997","journal-title":"Ann Med Intern"},{"key":"10.1016\/j.survophthal.2005.04.009_bib452","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/rheumatology\/40.2.192","article-title":"Anticardiolipin antibodies in Beh\u00e7et's disease: a reassessment","volume":"40","author":"Tokay","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib453","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/bjo.86.5.521","article-title":"High dose intravenous steroid therapy for severe posterior segment uveitis in Beh\u00e7et's disease","volume":"86","author":"Toker","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib454","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/gut.49.5.725","article-title":"Treatment of intestinal Beh\u00e7et's syndrome with chimeric tumor necrosis factor \u03b1 antibody","volume":"49","author":"Travis","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.survophthal.2005.04.009_bib455","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1006\/clim.1999.4687","article-title":"Enhancement of endothelial cell E-selectin expression by sera from patients with active Beh\u00e7et's disease: moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels","volume":"91","author":"Triolo","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib456","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/ard.61.6.560","article-title":"Anti-tumor necrosis factor monoclonal antibody treatment for ocular Beh\u00e7et's disease","volume":"61","author":"Triolo","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib457","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.echo.2003.09.009","article-title":"Beh\u00e7et's aortitis and aortic regurgitation: a report of two cases","volume":"17","author":"Tsui","year":"2004","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.survophthal.2005.04.009_bib458","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Beh\u00e7et's disease: an analysis of 880 patients","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib459","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0002-9394(03)00791-8","article-title":"Childhood-onset uveitis in Beh\u00e7et disease: a descriptive study of 36 cases","volume":"136","author":"Tugal-Tutkun","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib460","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2214\/ajr.172.3.10063870","article-title":"CT findings of pulmonary artery aneurysms during treatment for Beh\u00e7et's disease","volume":"172","author":"Tunaci","year":"1999","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib461","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/ard.2003.018515","article-title":"Cerebral venous thrombosis is associated with major vessel disease in Beh\u00e7et's syndrome","volume":"63","author":"Tun\u00e7","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib462","first-page":"128","article-title":"Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Beh\u00e7et's disease; soluble TNFR-75 as a biological marker of disease activity","volume":"24","author":"Turan","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib463","first-page":"31","article-title":"Plasma malondialdehyde levels in Beh\u00e7et's disease with or without ocular involvement","volume":"4","author":"T\u00fcrk\u00f6z","year":"2000","journal-title":"Adv Reprod"},{"key":"10.1016\/j.survophthal.2005.04.009_bib464","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-4362.2003.01741.x","article-title":"Evaluation of clinical findings according to sex in 2313 Turkish patients with Beh\u00e7et's disease","volume":"42","author":"Tursen","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib465","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-4362.1996.tb03683.x","article-title":"Epidemiology of Beh\u00e7et's syndrome in Turkey","volume":"35","author":"T\u00fcz\u00fcn","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib466","first-page":"179","article-title":"Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Beh\u00e7et's disease and Vogt-Koyanagi-Harada's disease","volume":"17","author":"Uchio","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib467","first-page":"469","article-title":"A famous Turkish dermatologist, Dr. Hulusi Beh\u00e7et","volume":"12","author":"\u00dcst\u00fcn","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib468","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1346-8138.2003.tb00423.x","article-title":"The clinical course of Beh\u00e7et's disease in pregnancy: a retrospective analysis and review of the literature","volume":"30","author":"Uzun","year":"2003","journal-title":"J Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib469","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","article-title":"Beh\u00e7et's disease, the Silk Road and HLA-B51: historical and geographical perspectives","volume":"54","author":"Verity","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.survophthal.2005.04.009_bib470","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-2370.2000.00202.x","article-title":"Intercellular adhesion molecule-1 gene polymorphism in Beh\u00e7et's disease","volume":"27","author":"Verity","year":"2000","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.survophthal.2005.04.009_bib471","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0002-9394(99)00184-1","article-title":"Factor V Leiden mutation is associated with ocular involvement in Beh\u00e7et disease","volume":"128","author":"Verity","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib472","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1076\/ocii.6.2.81.4054","article-title":"Soluble adhesion molecules in Beh\u00e7et's disease","volume":"6","author":"Verity","year":"1998","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2005.04.009_bib473","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1034\/j.1399-0039.1999.540307.x","article-title":"HLA and tumour necrosis factor (TNF) polymorphisms in ocular Beh\u00e7et's disease","volume":"54","author":"Verity","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.survophthal.2005.04.009_bib474","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5070\/D36WP569XX","article-title":"Beh\u00e7et's disease with relapsing cutaneous polyarteritis-nodosa-like lesions, responsive to oral cyclosporine therapy","volume":"9","author":"Vikas","year":"2003","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.survophthal.2005.04.009_bib475","first-page":"1383","article-title":"Exudative retinal detachment in Beh\u00e7et's disease","volume":"119","author":"Vrabec","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib476","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/cyto.1997.0297","article-title":"Activated human neutrophils express vascular endothelial growth factor (VEGF)","volume":"10","author":"Webb","year":"1998","journal-title":"Cytokine"},{"key":"10.1016\/j.survophthal.2005.04.009_bib477","first-page":"542","article-title":"Cardiovascular manifestations of Beh\u00e7et's disease","volume":"150","author":"Wechsler","year":"1999","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.survophthal.2005.04.009_bib478","first-page":"14","article-title":"Infliximab in refractory uveitis due to Beh\u00e7et's disease","volume":"22","author":"Wechsler","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib479","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0161-6420(96)30567-8","article-title":"A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis","volume":"103","author":"Whincup","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib480","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9394(14)72840-5","article-title":"Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Beh\u00e7et's disease","volume":"118","author":"Whitcup","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib481","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/eji.1830241103","article-title":"Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease","volume":"24","author":"Wildner","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib482","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1152\/jappl.2000.89.6.2382","article-title":"Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lepob) mice","volume":"89","author":"Winters","year":"2000","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib483","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0738-081X(99)00093-0","article-title":"Dapsone: unapproved uses or indications","volume":"18","author":"Wolf","year":"2000","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib484","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0002-9440(10)65601-5","article-title":"Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway","volume":"153","author":"Xiong","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib485","first-page":"1921","article-title":"Association of MICA gene and HLA-B\u22175101 with Beh\u00e7et's disease in Greece","volume":"40","author":"Yabuki","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2005.04.009_bib486","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/01.ijg.0000146624.31345.33","article-title":"Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Beh\u00e7et disease","volume":"13","author":"Yalva\u00e7","year":"2004","journal-title":"J Glaucoma"},{"key":"10.1016\/j.survophthal.2005.04.009_bib487","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bjo.77.9.584","article-title":"Cellular autoimmunity to retinal specific antigens in patients with Beh\u00e7et's disease","volume":"77","author":"Yamamoto","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib488","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/08830189709116841","article-title":"Hyperreactivity of neutrophils and abnormal T cell homeostasis: a new insight for pathogenesis of Beh\u00e7et's disease","volume":"14","author":"Yamashita","year":"1997","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib489","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2249.1997.274-ce1159.x","article-title":"Role of \u03b3\u03b4 T lymphocytes in the development of Beh\u00e7et's disease","volume":"107","author":"Yamashita","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib490","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7326\/0003-4819-124-10-199605150-00005","article-title":"Successful treatment of Beh\u00e7et disease with pentoxifylline","volume":"124","author":"Yasui","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib491","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1002\/art.20597","article-title":"Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Beh\u00e7et's disease","volume":"50","author":"Yasuoka","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib492","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/bjo.83.12.1386","article-title":"CD56+ T cells in the peripheral blood of uveitis patients","volume":"83","author":"Yato","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib493","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.2004.06003.x","article-title":"Increased advanced oxidation protein products in Beh\u00e7et's disease: a new activity marker?","volume":"151","author":"Yazici","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib494","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/rheumatology\/35.2.139","article-title":"The ten-year mortality in Beh\u00e7et's syndrome","volume":"35","author":"Yazici","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib495","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0002-9343(01)01081-6","article-title":"Beh\u00e7et's syndrome: where do we stand?","volume":"112","author":"Yazici","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib496","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2165\/00003495-199142050-00006","article-title":"Practical treatment recommendations for pharmacotherapy of Beh\u00e7et's syndrome","volume":"42","author":"Yazici","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.survophthal.2005.04.009_bib497","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.43.1.74","article-title":"A comparative study of the pathergy reaction among Turkish and British patients with Beh\u00e7et's disease","volume":"43","author":"Yazici","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2005.04.009_bib498","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000060761","article-title":"Medical management of Beh\u00e7et's syndrome","volume":"31","author":"Yazici","year":"1999","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib499","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Beh\u00e7et's syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"New Engl J Med"},{"key":"10.1016\/j.survophthal.2005.04.009_bib500","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00002281-200101000-00004","article-title":"Beh\u00e7et disease","volume":"13","author":"Yazici","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib501","unstructured":"Ye\u015filova Z, Pay S, \u00d6ktenli C, et al: Hyperhomocysteinemia in patients with Beh\u00e7et's disease: is it due to inflammation or therapy? Rheumatol Int (in press)"},{"key":"10.1016\/j.survophthal.2005.04.009_bib502","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00006982-200206000-00012","article-title":"Aqueous humor nitric oxide levels in patients with Beh\u00e7et disease","volume":"22","author":"Yilmaz","year":"2002","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2005.04.009_bib503","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ophtha.2003.07.018","article-title":"Comparison of patients with Beh\u00e7et's disease in the 1980s and 1990s","volume":"111","author":"Yoshida","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib504","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1378\/chest.120.2.688-a","article-title":"Cardiac thrombus in Beh\u00e7et disease","volume":"120","author":"Yoshida","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.survophthal.2005.04.009_bib505","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/10715769809097874","article-title":"Serum of Beh\u00e7et's disease enhances superoxide production of normal neutrophils","volume":"28","author":"Yoshida","year":"1998","journal-title":"Free Radic Res"},{"key":"10.1016\/j.survophthal.2005.04.009_bib506","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2249.2004.02536.x","article-title":"The number of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Beh\u00e7et's uveitis","volume":"137","author":"Yu","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib507","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/rheumatology\/keh056","article-title":"Failure of infliximab treatment and occurrence of erythema nodosum during therapy in two patients with Beh\u00e7et's disease","volume":"43","author":"Y\u00fccel","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib508","first-page":"820","article-title":"The prevalence of Beh\u00e7et's syndrome in a rural area in northern Turkey","volume":"15","author":"Yurdakul","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib509","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00002281-200401000-00008","article-title":"Beh\u00e7et syndrome","volume":"16","author":"Yurdakul","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib510","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Beh\u00e7et's syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2005.04.009_bib511","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0161-6420(03)00265-3","article-title":"Conjunctival ulcers in Beh\u00e7et's disease","volume":"110","author":"Zamir","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2005.04.009_bib512","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3349\/ymj.1997.38.6.411","article-title":"Epidemiological features of Adamantiades-Beh\u00e7et's disease in Germany and in Europe","volume":"38","author":"Zouboulis","year":"1997","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.survophthal.2005.04.009_bib513","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archderm.134.8.1010","article-title":"Treatment of Adamantiades-Beh\u00e7et disease with systemic interferon-\u03b1","volume":"134","author":"Zouboulis","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.survophthal.2005.04.009_bib514","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1210\/jcem.82.12.4408","article-title":"Tumor necrosis factor increases serum leptin levels in humans","volume":"82","author":"Zumbach","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.survophthal.2005.04.009_bib515","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0198-8859(98)00128-1","article-title":"Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes","volume":"60","author":"Zwirner","year":"1999","journal-title":"Hum Immunol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625705000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625705000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:28:53Z","timestamp":1758540533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625705000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":515,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0039625705000500"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2005.04.009","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Concepts in the Etiology and Treatment of Beh\u00e7et Disease","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2005.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}